Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
2021 Cell & Gene Therapy Report
2021 Monoclonal Antibody & Recombinant Protein Market Report
2022 Sterile Drug Market Report
2022 API Market Report
2022 OSD Market Report
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Drug Discovery (2)
173 Articles Available
2
8
Can't find what you're looking for? Try our
advanced search
.
Neurodegenerative Diseases
Uncovering New Drug Targets for Neurological Diseases
PAO-02-022-CL-10
Respiratory Diseases
Developing a Novel Anti-Inflammatory for Patients with Severe Asthma
PAO-02-022-CL-13
Oncology
Fighting Cancer by Focusing on Nuclear Export
PAO-02-022-CL-06
Drug Discovery
Designing More Effective Therapeutic Proteins Using an Integrated Laboratory and Computational Platform
PAO-02-022-CL-11
Analytical Services
Expecting More for Drug Discovery and Development
PAO-03-22-R250-05
Biotechnology
Solving Problems through Creative Applications of Science
PAO-02-22-R250-16
COVID-19 Antiviral
Model Medicines' Oral Anti-COVID-19 Drug Candidate MDL-001 Found to Significantly Reduce Viral Load in Lungs; Accepted into NIH's Antiviral Program for Pandemics (APP)
PR-M02-22-05
Strategic Alliance
FUJIFILM Cellular Dynamics and PhenoVista Biosciences Announce Strategic Alliance to Improve the Drug Discovery Process
PR-M01-22-05
Life Science Industrials
Filling Industry Gaps and Driving Innovation with Life Science Industrials
PAO-11-21-CL-01
Virtual Reality
Perception is Reality: Integrating Virtual and Augmented Reality Across Pharma
PAO-04-21-NI-02
Plant-Based
Exploring the Natural Pharmacopeia and Incubating a Biotech Company
PAO-02-21-CL-06
Tissue Models
The Power of RepliGut In Vitro Intestinal Stem Cell Models
M&A
AbCellera Expands Technology Stack with Acquisition of Trianni for $90 Million
PR-M11-20-018
Microphysiological Systems
Accelerating Drug Development with Microphysiological Systems (MPS)
PAP-Q3-20-CL-003
Endocannabinoid System
Realizing the Promise of Therapeutics Targeting the Endocannabinoid System
PAP-Q3-20-CL-005
Chronokines
Delivering Breakthrough Medicines for Rare Hematologic Diseases and Cancers
PAP-Q2-20-CL-003
Molecules
Molecules that Changed Medicine
PAP-Q2-20-NI-002
Chronokines
Solving Unmet Clinical Needs by Harnessing the Science of Aging
PAP-Q2-20-CL-013
Cancer Therapies
Computational Discoveries for Clinical Development of Novel Cancer Therapies
PAP-Q2-20-CL-014
Drug Repositioning
A Therapeutic Strategy for Neurological Disorders
PAP-Q2-20-CL-016
Immunotherapy
Leveraging the Native Immune Response to Fight Cancer
PAP-Q2-20-CL-017
Novel Antibiotics
Applying a Synthetic Approach to the Development of a New Generation of Antibiotics
PAP-Q2-20-CL-019
Epigenetics
Epigenetic Regulation to Treat Acute Organ Injury and Chronic Liver Diseases
PAP-Q2-20-CL-022
Endocrine Diseases
Developing Transformative Treatments for Rare Endocrine Diseases
PAP-Q2-20-CL-023
«
2
8
»
